Table of contents

Therapeutics

• Review: evidence does not support a reduction in sexual reoffending with psychological interventions, but further high-quality trials are needed (20 April, 2013) Free
• Review: limited evidence that risperidone reduces aggression and conduct problems in the short term in children and adolescents with disruptive behaviour disorders (16 April, 2013)
• Review: psychosocial interventions improve early disruptive behaviour in very young children (20 April, 2013)
• Review: in alcohol use disorders, acamprosate is more effective for inducing abstinence while naltrexone is more effective for reducing heavy drinking and craving (20 April, 2013)
• Implementing an antidepressant treatment strategy for post-MI depression does not reduce risk of further cardiovascular events or mortality (20 April, 2013)
• Review: no reliable evidence of the effect of psychotherapy upon suicide risk in people with depression (13 April, 2013)
• The mental health effects on adolescents of moving from a high- to low-poverty neighbourhood differ by gender and baseline health vulnerability (21 May, 2013)
• Higher dose l-methylfolate may be an effective adjunctive therapy for adults with major depression who have inadequate response to SSRIs

  (26 April, 2013)
• Primary care management of opioid dependence: the addition of CBT gives no extra benefit compared to standard physician management alone (24 April, 2013)
• Artificial food colour exclusion and free fatty acid supplementation may reduce symptom severity in children with ADHD (23 May, 2013)
• Family presence during resuscitation attempts is associated with positive psychological effects for the observers (23 May, 2013)
• Limited evidence that neurolinguistic programming improves health-related outcomes (30 May, 2013)
• No difference in psychosocial and mental health outcomes for clients receiving statutory mental health services from consumer-providers compared to professionals (13 June, 2013)
• Antipsychotics can be withdrawn from many older people with dementia, though caution is needed for people with more severe neuropsychiatric symptoms (13 June, 2013)
• Review: SSRIs and TCAs equally effective at treating chronic depression and dysthemia; SSRIs are associated with fewer adverse events than TCAs (20 April, 2013)
• Cognitive therapy may reduce psychotic symptom severity but not risk of transition to psychosis in young people at high risk (21 May, 2013)